Where I see patients (1)
My reviews
Selected research
-
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702.
Leukemia
-
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.
Blood
-
A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma.
Future oncology (London, England)
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.8